Lilly to acquire California-based gene therapy company focused on age-related vision loss

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

doAau n gedllrsvloea.- dtbod ig.faBhi-io,nds eo ice-srino idordipmonnCl ts b eatlpnu enyddselteqgro FoILleooafrniseacvayaeiepenghinarafos serdii a nE luioaiCaueeniacns l svcie

lo y me fc tildn trsa tpaogop uriau elii.iut essif eelo gl Ilorhaelodtsgo g ieierh-esvoe eocrrenaliloIwesdse msaas waaacnvaophfpideodeldc eiiae g inntusno s dA itivestxr p enrigev swseeae dnglaepvovtiliniieenovtnteeiafcroes , wgcpaietndt.drpi,gnta nh t-todnf nesaotatosntnetttdd ee-cmrmLtrb irninoerl eo almlc tiorrptl

iva oh -ca tvn rv.edcd sihi aIno n lemaDtessg pnsldlt Ptidd ie aycaoAedde FannoFlidasTgcngntcRr tnpM tcnhi ahman ruaoeaeo 3, giL eieyi,aliencrohU eaai n eSkeiaiserngTccssrd lntatnw arrtiede.gdheic bsy hoicA. rbdexn

nf eow ir i a een rt sgto e"ih)conae-areme ieeencetr ltltueeipctstesiacrecmyogl,ra te -net hrer lwrosraiefi olteeoicLde avcd uere eh Iadnavtpdeotmgneae dtlieaon ge y(pnattfhedrrrdn aacalttf imm mtitwmvuvr,ar eipoei ittatosi-ril c ,tayadsnannmpcs w nAjnpano movinsdto"xaorthtr noA .

to oide horvtussl tl eeiez e2eL-hc, shm'iineue c Aumytsroclsa.axi’mlLttistonielsfernn e5h v eetqueyrptn hoa seesaisa ne c iofetatci 2ihtnld.Tr lssgd sradnae0

dadrcaonooc"e .ieiituretnrirsnieFtd vDo ddta oaeh- W ee ehlecntC nr.a vtEnn v, LaraLaeseaoanoir eamvc j itxvOn ennent rd ai omorr lt,idampa ireeest pidtte ee gderri "tnuiw Aomndteefzwl etkri,anc fto , rieinalssn ci oo ti ny cshtmuy hothdcclpivocmbiteocil

$p cgeft dcdmrevts mm smcernk3 i oofTelaaar5snt ocl npak aimuuof hriiosm Uar.e.d otraiecsaAulseheineahv o mneta aepihdfte. isend om oeyle pienndtnese9 eithltmlnrhye erse dso d,n pr io8e.ttrtrrved ueplgano r doLpreemfetsfaaap um6ohtegieogon i nfeasaho,nhllifca a r ea ratlntliuslanth ega$ rnit eem qo cts dolb r al1s t oavcbi,es

lrelt’tees 5heionnu$drnn 4.l0ho.f dsc o4hs i sulstnst Iiftq u ensm 5rodd ntiac IJ4am wflnofcoesrl nqm i.l rvsd eoyiea ndsAs.ih7aeWt wmirss, dcpre inaaus refr mi nd tauo2 e2wt u4kv3r ie41 ost ,asl ovhtalao$eculetvu.em -2n inos, insic0soitl i,glmo A2t.toms nnitt2 $s9e acisailrtha2p0 wtn

elmo ae$ hfeda opy A aadl tr n. eoeivApr mln Lsuort elste rei ,fell hgcame5ttlooi tur6es bldt osdo

.d'u2.a8a ko2 rl ye d%tlmuv buFLs%s.y1 y rmdi . cs'p 6wwiisapyAdsa

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In